Post-Traumatic Stress Disorder Treatment Market to Reach $26.1 Billion, Globally, by 2031 at 4.9% CAGR

Allied Market Research published a report, titled, 'Post-Traumatic Stress Disorder Treatment Market by Treatment Type (Drugs, Pyschotherapy), By Age Group (Pediartic, Geriatric, Adult), By End User (Hospitals, Outpaitent Clinics, Mental Health Center, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031.' According to the report, the global post-traumatic stress disorder treatment industry was estimated at $16.0 billion in 2021, and is anticipated to hit $26.1 billion by 2031, registering a CAGR of 4.9% from 2022 to 2031.

Download Report (245 Pages PDF with Insights, Charts, Tables, Figures):
https://www.alliedmarketresearch.com/request-sample/12965

Prime determinants of growth-

Increase in the number of clinical trials pertaining to post-traumatic stress disorder treatment and rise in R&D activities for the introduction of novel therapies and drugs drive the growth of the global post-traumatic stress disorder treatment market. Moreover, surge in government initiatives for post-traumatic stress disorder treatment & management and growing healthcare expenditure in developing countries are expected to pave the way for lucrative opportunities in the industry.

Covid-19 Scenario-

During the global health crisis, a large number of patients witnessed a decline in psychotherapies, which in turn gave way to increasing adoption of drugs and medication intended for the treatment of the post-traumatic disorder treatment market. This factor impacted the market positively.
This trend is going to continue until the pandemic is over.
Scope of the Report: -

Report Attribute

Details

Revenue forecast in 2030

USD 26.1 billion

Growth rate

CAGR of 4.9% from 2022 to 2031

Forecast period

2022 - 2031

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Regional scope

North America, Europe, Asia Pacific, Latin America, MEA

Country scope

U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, China, India, South Korea, Australia, Brazil, Mexico, South Africa, Saudi Arabia

Key companies profiled -

Acadia Healthcare,
Behavioral Health Network, Inc.,
CareTech Holdings Plc,
GlaxoSmithKline Plc,
Pfizer, Inc,
Viatris, Inc,
Strategic Behavioral Health,
Ascension Seton,
North Range Behavioral Health,
Pyramid Healthcare and Eily Lilly and Company

The psychotherapy segment to dominate by 2031-

By treatment type, the psychotherapy segment contributed to the major share in 2021, holding more than two-thirds of the global post-traumatic stress disorder market. Rise in the prevalence of post-traumatic stress disorder and the surge in initiatives by governments for treating their war veterans have led to increased demand for PTSD therapeutics across the world, thus propelling the segment growth. The drugs segment, however, would cite the fastest CAGR of 6.5% during the forecast period.

Specific Requirement on COVID-19? Ask to Our Industry Expert:
https://www.alliedmarketresearch.com/request-for-customization/12965?reqfor=covid

The adult segment to maintain the lion's share-

By age group, the adult segment accounted for the major share in 2021, holding nearly half of the global post-traumatic stress disorder market. Rise in violence, cross-border tensions, accidents, and occupational hazards across the world fuel the growth of the segment. The pediatric segment, on the other hand, is expected to grow at the fastest CAGR of 5.9% from 2022 to 2031, due to increase in mental and physical abuse cases.

North America Post-Traumatic Stress Disorder Treatment Market Garnered the Major Share in 2021-

By region, the market across North America had the lion's share in 2021, generating around two-fifths of the global post-traumatic stress disorder market. This is attributed to the increasing burden of post-traumatic stress disorders, rise in research and development activities, and presence of strong and established market players across the province. Asia-Pacific, simultaneously, is projected to portray the fastest CAGR of 6.2% by 2031, owing to surge in number of mental and sexual abuse among adults in the region.

Key players in the industry -

Behavioral Health Network, Inc.
CareTech Holdings Plc
GlaxoSmithKline Plc
Viatris, Inc
North Range Behavioral Health
Strategic Behavioral Health
Pyramid Healthcare
Pfizer, Inc
Eily Lilly and Company
Acadia Healthcare
Ascension Seton
Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the post-traumatic stress disorder treatment market analysis from 2021 to 2031 to identify the prevailing post-traumatic disorder treatment market opportunities.
The Market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the post-traumatic stress disorder treatment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global post-traumatic disorder treatment market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments

By Treatment Type

Drugs
Pyschotherapy

By Age Group

Pediartic
Geriatric
Adult

By End User

Mental Health Center
Others
Hospitals
Outpaitent Clinics

By Region

North America
U.S.
Canada
Mexico
Europe
Spain
Rest of Europe
Germany
France
U.K.
Italy
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

►►► Exclusive Related Reports with (Full Complimentary PDF - Download Now): ►►►

Healthcare Facility Management Market - https://www.alliedmarketresearch.com/healthcare-facility-management-market-A17281
Drug Screening Laboratory Services Market - https://www.alliedmarketresearch.com/drug-screening-laboratory-services-market-A06642
Bioinformatics Market - https://www.alliedmarketresearch.com/bioinformatics-market
Medical Spa Market - https://www.alliedmarketresearch.com/medical-spa-market

Contact Us:

United States
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.